These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9194149)

  • 1. Modulation of apomorphine-induced stereotyped behavior by cholecystokinin.
    Tieppo CA; Nasello AG; Felicio LF
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 May; 21(4):683-95. PubMed ID: 9194149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin modulation of apomorphine- or amphetamine-induced stereotypy in rats: opposite effects.
    Tieppo CA; Felicio LF; Nasello AG
    Peptides; 2001 Aug; 22(8):1291-8. PubMed ID: 11457523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats.
    Tieppo CA; Silva AM; Palermo-Neto J; Nasello AG; Felicio LF
    Braz J Med Biol Res; 1995 Mar; 28(3):351-4. PubMed ID: 8520531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy.
    Cohen SL; Knight M; Tamminga CA; Chase TN
    Eur J Pharmacol; 1982 Sep; 83(3-4):213-22. PubMed ID: 6129145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of either cholecystokinin receptor subtype reduces while antagonists potentiate or sensitize a morphine-induced excitatory response.
    Felicio LF; Mazzini BK; Cacheiro RG; Cruz TN; Flório JC; Nasello AG
    Peptides; 2001 Aug; 22(8):1299-304. PubMed ID: 11457524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
    Tieppo CA; Ferreira FS; Sassatani AS; Felicio LF; Nasello AG
    Eur J Pharmacol; 2000 Jan; 387(2):189-96. PubMed ID: 10650159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide modulation of apomorphine-induced stereotyped behavior.
    Blumstein LK; Crawley JN; Davis LG; Baldino F
    Brain Res; 1987 Feb; 404(1-2):293-300. PubMed ID: 3567572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats.
    Hara C; Kastin AJ
    Pharmacol Biochem Behav; 1986 Oct; 25(4):757-61. PubMed ID: 2878442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice.
    Worms P; Martinez J; Briet C; Castro B; Biziere K
    Eur J Pharmacol; 1986 Mar; 121(3):395-401. PubMed ID: 3699101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of some antidepressant drugs on apomorphine concentration in the central nervous system of rats and apomorphine-induced stereotypy.
    Rurak A; Melzacka M
    Pol J Pharmacol Pharm; 1985; 37(4):509-15. PubMed ID: 3866221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of d,l-propranolol on apomorphine induced stereotyped behavior in rats.
    Poli A; Palermo-Neto J
    Gen Pharmacol; 1987; 18(2):149-52. PubMed ID: 3569842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cholecystokinin on apomorphine-induced changes of motility in rats.
    Katsuura G; Itoh S; Rehfeld JF
    Neuropharmacology; 1984 Jul; 23(7A):731-4. PubMed ID: 6089021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alpha-adrenergic blocking agents on stereotyped behavior induced by apomorphine in rats.
    De-Souza H; Palermo-Neto J
    Braz J Med Biol Res; 1982 Jul; 15(2-3):143-6. PubMed ID: 6891277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL; Szabó G; Penke B; Telegdy G
    Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural manifestations elicited by apomorphine, influence of the route of administration.
    Barros HM; Braz S; Carlini EA
    Pharmacology; 1989; 38(5):335-40. PubMed ID: 2762376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed D2/5-HT2 antagonism differentially affects apomorphine- and amphetamine-induced stereotyped behavior.
    Feldman DJ; Frank RA; Kehne JH; Flannery R; Brown D; Soni S; Byrd G; Shah S
    Pharmacol Biochem Behav; 1997 Oct; 58(2):565-72. PubMed ID: 9300620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-histidine and promethazine on apomorphine and amantadine stereotypy in rats.
    Balsara JJ; Dhavare BS; Nandal NV; Chandorkar AG
    Psychopharmacology (Berl); 1983; 79(4):372-4. PubMed ID: 6407056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
    Lane RF; Blaha CD; Phillips AG
    Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine.
    Mattingly BA; Caudill A; Abel M
    Pharmacol Biochem Behav; 2001 Mar; 68(3):417-26. PubMed ID: 11325394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.